The latest innovation and commercialization news from The Texas A&M University System.
|
|
|
(l-r) Dr. Robert Balog and Dr. Jaime Grunlan
|
Two Inventors Named 2024 Fellows of the National Academy of Inventors
|
Dr. Robert Balog, a professor in the Department of Electrical and Computer Engineering, and Dr. Jaime Grunlan, the Leland T. Jordan ’29 Chair Professor of Mechanical Engineering, have been named as 2024 Fellows of the National Academy of Inventors (NAI). This prestigious honor recognizes academic inventors whose innovative contributions have made a tangible impact on society. Read more.
|
|
|
InnovationU: Building Strong Startup Companies at Texas A&M
|
Join us on February 4, 2025, from 4:30-6:30 pm at the Memorial Student Center (MSC), Room 2406 on the College Station campus or virtually for a conversation with Texas A&M Innovation’s head of new ventures for The Texas A&M University System, Dr. Samuel Kim, and the CEO of Electroninks discussing key ingredients for a successful startup company. Register now!
|
|
|
2024 Chancellor's Awardee Dr. Gerard Cote pictured with Dr. Joe Elabd, Chancellor John Sharp, and Pete ONeill.
|
Nominations Open for 2025 Chancellor's Innovation Award
|
The 2025 Patent and Chancellor's Innovation Awards Luncheon will be held on April 11, 2025. We are currently seeking nominations for the Chancellor's Innovation Award. Self-nominations and nominations by colleagues will be accepted and should demonstrate achievement of commercialization results. Read more.
|
|
|
Texas A&M Startup Sano Chemicals Announces Promising Clinical Trial Results for Occidiofungin, the Fungus KillerTM
|
Texas A&M startup Sano Chemicals has announced the successful completion of its Phase 1 human clinical trial for Occidiofungin, the first-in-class antifungal agent designed to treat recurrent vulvovaginal candidiasis (RVVC), commonly known as recurrent vaginal yeast infections. The company is now seeking investors to propel Occidiofungin into the next phase of development. This groundbreaking development marks a significant step forward in addressing an unmet medical need affecting millions of women worldwide. Read more.
|
|
|
Upcoming Spring 2025 Events - Save the Dates!
|
February 4: InnovationU
February 26: AgTech Innovation Summit at the Houston Rodeo
March 5: Aerospace & Defense Innovation Triangle Launch
April 16: InnovationU
May 14-15: Texas A&M New Ventures Competition
November 11-13: Innovation Forward (IF2025)
|
|
|
New Team Member Spotlight: Francisca Patcha
|
Francisca is a new addition to the Texas A&M Innovation Team. She assists Brenda as a Reporting Coordinator by compiling, analyzing and interpreting data from the internal IP management database to inform data-driven decision making for The Texas A&M University System. Even though... Read more.
|
| Related News Across the A&M System
|
|
|
Six patents were issued to The Texas A&M University System during the month of December. Congratulations to the inventors!
|
-
Angelman Syndrome Antinsense Treatment
- Inventor: Scott Dindot
- Japan Patent No. 7601441
- Protein Inhibitors of Clostridium Difficile Toxin B
- Inventors: Zhilei Chen, Rudo Simeon, Ana Chamoun-Emanuelli, Zeyu Peng
- United States Patent No. 12,161,691
-
Methods and Compositions for Treatment and Control of Plant Disease
- Inventors: Ryland Young, Carlos Gonzalez, Mayukh Das, Stephen Ahern, Tushar Suvra Bhowmick
- Japan Patent No. 7602815
-
Angelman Syndrome Antisense Treatment
- Inventor: Scott Dindot
- United States Patent No. 12,180,480
-
Amyloid Peptide Scaffolds Coordinate with Alzheimer’s Disease Drugs
- Inventors: Phanourios Tamamis, Sai Vamshi Reddy Jonnalagadda
- United States Patent No. 12,178,878
-
Cryogenic Separation of Carbon Dioxide, Sulfur Oxides, and Nitrogen Oxides from Flue Gas
- Inventors: Mark Holtzapple, M.M. Faruque Hasan, Mohammed Sadaf Monjur
- United States Patent No. 12,179,145
|
|
|
|
Texas A&M Innovation is focused on harvesting new innovations, protecting intellectual property, and facilitating the commercialization process to move Texas A&M University System technologies from the lab to the marketplace. For more information on about how we can partner with you as a university researcher or industry collaborator, please contact us.
innovation@tamus.edu | innovation.tamus.edu
|
|
|
Manage your preferences | Opt Out using TrueRemove™
Got this as a forward? Sign up to receive our future emails.
View this email online.
|
175 Century Square One Suite 200 | College Station, TX 77840 US
|
|
|
This email was sent to ccarter@tamus.edu.
To continue receiving our emails, add us to your address book.
|
| |
|
|
